FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

RSVpreF Vaccine Meets Endpoints

Pfizer-supported research shows its investigational bivalent RSV prefusion F protein-based vaccine succeeded in preventing RSV-associated lower respir...

latest-news-card-1
Human Drugs

Mutagenic Impurities Guideline Adopted

The International Council for Harmonization gives final approval to a guidance on assessing and controlling mutagenic impurities in drugs to limit can...

latest-news-card-1
Medical Devices

FDA Wants MDUFA 5 PPI Input

FDA asks for input on five questions that could be included in a revision of a medical device patient perspective guidance.

latest-news-card-1
Federal Register

Comments Extended on Neurodevelopmental Study Guide

Federal Register notice: FDA extends the comment period for a draft guidance entitled Considerations for Long-Term Clinical Neurodevelopmental Safety ...

latest-news-card-1
Biologics

Untitled Letter Sent to Fidia Pharma

CBER issues an untitled letter to Fidia Pharma USA after reviewing the companys Web sites and determining that its cell/tissue products require a BLA ...

latest-news-card-1
Federal Register

Guide on Clinical Outcome Assessments

Federal Register notice: FDA makes available a draft guidance on incorporating clinical outcome assessments into endpoints.

latest-news-card-1
Federal Register

Guide on Drug Mfg. Discontinuance/Interruptions

Federal Register notice: FDA makes available a draft guidance entitled Notification of a Permanent Discontinuance or Interruption in Manufacturing Und...

latest-news-card-1
Human Drugs

FDA Pulls Makena Approval Immediately

FDA commissioner Robert Califf and chief scientist Namandj Bumpus withdraw Covis Pharmas preterm birth drug Makena and its generics from the market ef...

latest-news-card-1
Medical Devices

FDA Clears restor3D 510(k) for Ankle Device

FDA clears a restor3d 510(k) for the Axiom PSR System for use with the companys Kinos Axiom Total Ankle System.

latest-news-card-1
Human Drugs

2 Texas Men Plead Guilty to Misbranded Drug Sales

The Justice Department says two Texas men face up to five years in prison after pleading guilty to selling misbranded drugs over the Internet.